Literature DB >> 18097621

A novel activation-induced suicidal degradation mechanism for Akt by selenium.

Ji-Hyun Lee1, Sun Hye Shin, Seongman Kang, Yun-Sil Lee, Sangwoo Bae.   

Abstract

Selenium has been associated with an anti-cancer effect via the modulation of Akt. In order to investigate whether selenium modulates Akt by hitherto unidentified molecular mechanisms, we examined the effect of selenium on the stability and activity of Akt. Selenium induced destabilization of Akt which is coupled to its own enzyme activation. Mutation of T308 and S473 of Akt to alanine as well as the inhibition or depletion of upstream kinases for Akt activation blocked Akt degradation. These features of Akt degradation are reminiscent of the 'activation-induced suicidal degradation' mechanism. PTEN was also required for Akt destabilization as Akt activation alone was unable to elicit Akt degradation in the absence of PTEN. Conversely, PTEN introduction in PTEN-null prostate cancer cells restored the ability to degrade Akt upon selenium treatment. Collectively, selenium seems to achieve ultimate negative regulation of Akt signaling by destabilizing the protein, and this regulation mechanism might provide a paradigm for the anti-cancer activity of selenium.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18097621

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  9 in total

1.  Acyl-CoA synthetase VL3 knockdown inhibits human glioma cell proliferation and tumorigenicity.

Authors:  Zhengtong Pei; Peng Sun; Ping Huang; Bachchu Lal; John Laterra; Paul A Watkins
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

2.  Melanoma prevention using topical PBISe.

Authors:  Chin-Ying Chung; SubbaRao V Madhunapantula; Dhimant Desai; Shantu Amin; Gavin P Robertson
Journal:  Cancer Prev Res (Phila)       Date:  2011-03-02

3.  Activation of FOXO1 is critical for the anticancer effect of methylseleninic acid in prostate cancer cells.

Authors:  Haitao Zhang; Jian Fang; Dian Yao; Yue Wu; Clement Ip; Yan Dong
Journal:  Prostate       Date:  2010-09-01       Impact factor: 4.104

4.  Targeting Akt3 signaling in malignant melanoma using isoselenocyanates.

Authors:  Arati Sharma; Arun K Sharma; Subbarao V Madhunapantula; Dhimant Desai; Sung Jin Huh; Paul Mosca; Shantu Amin; Gavin P Robertson
Journal:  Clin Cancer Res       Date:  2009-02-10       Impact factor: 12.531

5.  Stimulation of Akt poly-ubiquitination and proteasomal degradation in P388D1 cells by 7-ketocholesterol and 25-hydroxycholesterol.

Authors:  June Liu; Courtney Netherland; Theresa Pickle; Michael S Sinensky; Douglas P Thewke
Journal:  Arch Biochem Biophys       Date:  2009-05-21       Impact factor: 4.013

6.  A case-control study of the risk of cutaneous melanoma associated with three selenium exposure indicators.

Authors:  Marco Vinceti; Catherine M Crespi; Carlotta Malagoli; Ilaria Bottecchi; Angela Ferrari; Sabina Sieri; Vittorio Krogh; Dorothea Alber; Margherita Bergomi; Stefania Seidenari; Giovanni Pellacani
Journal:  Tumori       Date:  2012 May-Jun

7.  Exosomal miRs in Lung Cancer: A Mathematical Model.

Authors:  Xiulan Lai; Avner Friedman
Journal:  PLoS One       Date:  2016-12-21       Impact factor: 3.240

8.  Novel library of selenocompounds as kinase modulators.

Authors:  Daniel Plano; Elena Ibáñez; Alfonso Calvo; Juan Antonio Palop; Carmen Sanmartín
Journal:  Molecules       Date:  2011-07-27       Impact factor: 4.411

9.  Synthesis of sp2-Iminosugar Selenoglycolipids as Multitarget Drug Candidates with Antiproliferative, Leishmanicidal and Anti-Inflammatory Properties.

Authors:  Elena M Sánchez-Fernández; Raquel García-Hernández; Francisco Gamarro; Ana I Arroba; Manuel Aguilar-Diosdado; José M Padrón; José M García Fernández; Carmen Ortiz Mellet
Journal:  Molecules       Date:  2021-12-11       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.